TL;DR: Forcyte Biotechnologies is a Y Combinator Winter 2021 startup Discover drugs that control how much cells "squeeze" to treat disease, currently inactive with a team of 5.
Discover drugs that control how much cells "squeeze" to treat disease
Last verified:
In a nutshell: many diseases are caused by how much your cells squeeze (asthma, fibrosis, others). We discover drugs that control how much cells squeeze, with ease, to treat disease. We use patented bioMEMS technology to turn cell strength (cells' ability to pull/ squeeze) into a quantifiable metric in drug discovery, to help find better drugs for mechanical diseases. We screen 100,000s of drugs against numerous contractile human cell types to comprehensively map human mechanobiology (the "contractome") and identify promising drug development starting points to deliver novel medicines to treat mechanically-driven diseases including asthma, hypertension, preterm labor, fibrosis, and others.
Built by LemStudio
Yes. Forcyte Biotechnologies was funded by Y Combinator in the Winter 2021 batch. Discover drugs that control how much cells "squeeze" to treat disease
In a nutshell: many diseases are caused by how much your cells squeeze (asthma, fibrosis, others). We discover drugs that control how much cells squeeze, with ease, to treat disease. We use patented bioMEMS technology to turn cell strength (cells' ability to pull/ squeeze) into a quantifiable metric in drug discovery,…
Forcyte Biotechnologies was part of Y Combinator's Winter 2021 batch.
Forcyte Biotechnologies has a team of 5 people according to Y Combinator's directory.
Forcyte Biotechnologies is currently listed as Inactive with a team of 5 in Y Combinator's directory.
Loading interactive view…